146 related articles for article (PubMed ID: 11260006)
1. Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study.
Durakovic C; Malabanan A; Holick MF
Br J Dermatol; 2001 Mar; 144(3):500-6. PubMed ID: 11260006
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of vitamin D3 derivatives in the treatment of psoriasis vulgaris: a preliminary report.
el-Azhary RA; Peters MS; Pittelkow MR; Kao PC; Muller SA
Mayo Clin Proc; 1993 Sep; 68(9):835-41. PubMed ID: 8396699
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis.
Pèrez A; Chen TC; Turner A; Raab R; Bhawan J; Poche P; Holick MF
Br J Dermatol; 1996 Feb; 134(2):238-46. PubMed ID: 8746336
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
5. Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.
Chen TC; Holick MF
Br J Dermatol; 2000 Jul; 143(1):72-8. PubMed ID: 10886138
[TBL] [Abstract][Full Text] [Related]
6. Treatment of psoriasis with calcipotriol and other vitamin D analogues.
Kragballe K
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):1001-8. PubMed ID: 1479078
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study.
Ring J; Kowalzick L; Christophers E; Schill WB; Schöpf E; Ständer M; Wolff HH; Altmeyer P
Br J Dermatol; 2001 Mar; 144(3):495-9. PubMed ID: 11260005
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
10. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.
Barker JN; Ashton RE; Marks R; Harris RI; Berth-Jones J
Br J Dermatol; 1999 Aug; 141(2):274-8. PubMed ID: 10468799
[TBL] [Abstract][Full Text] [Related]
11. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
13. Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial.
Holick MF; Chimeh FN; Ray S
Br J Dermatol; 2003 Aug; 149(2):370-6. PubMed ID: 12932245
[TBL] [Abstract][Full Text] [Related]
14. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
[TBL] [Abstract][Full Text] [Related]
15. Treatment of psoriasis vulgaris with topical calcipotriol has no short-term effect on calcium or bone metabolism. A randomized, double-blind, placebo-controlled study.
Mortensen L; Kragballe K; Wegmann E; Schifter S; Risteli J; Charles P
Acta Derm Venereol; 1993 Aug; 73(4):300-4. PubMed ID: 7904106
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
Liao YH; Chiu HC; Tseng YS; Tsai TF
Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
[TBL] [Abstract][Full Text] [Related]
18. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol ointment versus cream in psoriasis vulgaris.
Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis.
Tzung TY; Wu JC; Hsu NJ; Chen YH; Ger LP
Acta Derm Venereol; 2005; 85(3):236-9. PubMed ID: 16040409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
